ArticleEuropean journal of nuclear medicine and molecular imaging2026
Hemoglobin levels and myocardial blood flow in patients undergoing positron emission tomography.
Article in European journal of nuclear medicine and molecular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeMyocardial oxygen supply depends on both myocardial blood flow and its oxygen content, as reflected by blood hemoglobin levels. However, there is little data on the impact of hemoglobin levels on myocardial blood flow as captured by positron emission tomography (PET).
methodsConsecutive patients undergoing Rb-82 PET myocardial perfusion imaging (MPI) using regadenoson stress testing and hemoglobin levels available within 90 days of imaging were included. Patients with significant perfusion defects were excluded. Pearson correlation coefficients and multivariable Gamma regression models were used to study the association between myocardial flow reserve (MFR) and hemoglobin levels. The consistency of the prognostic value of MFR across different levels of hemoglobin was assessed using multivariable Andersen-Gill Cox models with robust standard errors.
resultsA total of 2,676 (median age: 67 years; 54.6% females) patients were included. Hemoglobin levels were negatively correlated with rest MBF (-0.33; P < 0.001), positively correlated with stress MBF (0.04; P: 0.04) and positively correlated with MFR (0.38; P < 0.001). In multivariable models, hemoglobin levels were more strongly associated with rest MBF than with stress MBF. The prevalence of microvascular dysfunction (MFR < 2) was significantly less common at higher hemoglobin levels, with an adjusted prevalence of 52.0%, 35.6%%, and 24.6% at hemoglobin levels of 10, 12, and 14 g/dL respectively. MFR was prognostic across the spectrum of hemoglobin, with no statistically significant evidence of an interaction (P for interaction = 0.269).
conclusionHemoglobin levels are negatively associated with rest MBF, weakly positively associated with stress MBF, and positively associated with MFR. The prevalence of microvascular dysfunction, reflected by an MFR < 2, is significantly higher in patients with lower hemoglobin levels. However, the prognostic value of MFR is maintained across the spectrum of hemoglobin levels.
Indexed as
Identifiers
41689646What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.